How is repatha stored

You are now leaving Amgen's website www.amgencare.ie and entering another website. Amgen is not responsible for the content of this third-party website you are entering now and is not adopting such content into this website. If you want to leave www.amgencare.ie please click continue:

You are now leaving Amgen's website www.amgencare.ie and entering another website. Amgen is not responsible for the content of this third-party website you are entering now and is not adopting such content into this website. If you want to leave www.amgencare.ie please click continue:

You are now leaving Amgen's website www.amgencare.ie and entering another website. Amgen is not responsible for the content of this third-party website you are entering now and is not adopting such content into this website. If you want to leave www.amgencare.ie please click continue:

Return to Previous Page Continue

How should Repatha® be stored?

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.
  • Store in a refrigerator (2°C to 8°C). Do not freeze.
  • Store in the original carton in order to protect from light.
  • Your pre-filled pen may be left outside the refrigerator to reach room temperature (up to 25°C) before injection. This will make the injection more comfortable. After removal from the refrigerator, Repatha® may be stored at room temperature (up to 25°C) in the original carton and must be used within 1 month.
  • Do not use this medicine if you notice it is discoloured or contains large lumps, flakes or coloured particles.
  • Do not throw away any medicines via wastewater or household waste.
  • Ask your doctor, pharmacist or nurse how to dispose of medicines you no longer use. These measures will help protect the environment.
about-repatha6

Contents of the Repatha® pack and other information

  • The active substance in Repatha® is evolocumab.
  • Each SureClick® pre-filled pen contains 140 mg of evolocumab in 1 ml of solution.
  • The other ingredients are proline, glacial acetic acid, polysorbate 80, sodium hydroxide, water for injections.
  • Repatha® is a solution which is clear to opalescent, colourless to yellowish, and practically free from particles.
  • Each pack contains two single-use SureClick® pre-filled pens.

More extensive information on Repatha® is available in the Patient Information Leaflet.

References:

  1. Repatha® (evolocumab) Patient Information Leaflet.

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Side effects can be reported directly to the Health Products Regulatory Authority (HPRA) using the available methods via www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. Side effects should also be reported to Amgen Limited on +44 (0) 1223 436441 or Freephone 1800 535 160.
Please report any potential quality issue with the Amgen product you have received, by calling us on +44 (0) 1223 436441 or Freephone 1800 535 160 and providing us with the details. Please ensure that you keep your packaging, so we are able to identify your product more easily.
For a list of possible side effects, please see
Patient Information Leaflet (PIL)

© 2021 Amgen Inc. All rights reserved | IE-REP-1020-00002 June 2021
Amgen Ireland Ltd - 21 Northwood Court, Santry, Dublin 9, Ireland